145 related articles for article (PubMed ID: 37556555)
21. SARS-CoV-2 infection of human-induced pluripotent stem cells-derived lung lineage cells evokes inflammatory and chemosensory responses by targeting mitochondrial pathways.
Surendran H; Kumar S; Narasimhaiah S; Ananthamurthy A; Varghese PS; D'Souza GA; Medigeshi G; Pal R
J Cell Physiol; 2022 Jul; 237(7):2913-2928. PubMed ID: 35460571
[TBL] [Abstract][Full Text] [Related]
22. SARS-CoV-2 Variants of Concern Infect the Respiratory Tract and Induce Inflammatory Response in Wild-Type Laboratory Mice.
Stone S; Rothan HA; Natekar JP; Kumari P; Sharma S; Pathak H; Arora K; Auroni TT; Kumar M
Viruses; 2021 Dec; 14(1):. PubMed ID: 35062231
[TBL] [Abstract][Full Text] [Related]
23. Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection.
Totura AL; Whitmore A; Agnihothram S; Schäfer A; Katze MG; Heise MT; Baric RS
mBio; 2015 May; 6(3):e00638-15. PubMed ID: 26015500
[TBL] [Abstract][Full Text] [Related]
24. Hamsters Expressing Human Angiotensin-Converting Enzyme 2 Develop Severe Disease following Exposure to SARS-CoV-2.
Golden JW; Li R; Cline CR; Zeng X; Mucker EM; Fuentes-Lao AJ; Spik KW; Williams JA; Twenhafel N; Davis N; Moore JL; Stevens S; Blue E; Garrison AR; Larson DD; Stewart R; Kunzler M; Liu Y; Wang Z; Hooper JW
mBio; 2022 Feb; 13(1):e0290621. PubMed ID: 35073750
[TBL] [Abstract][Full Text] [Related]
25. Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development.
Imai M; Iwatsuki-Horimoto K; Hatta M; Loeber S; Halfmann PJ; Nakajima N; Watanabe T; Ujie M; Takahashi K; Ito M; Yamada S; Fan S; Chiba S; Kuroda M; Guan L; Takada K; Armbrust T; Balogh A; Furusawa Y; Okuda M; Ueki H; Yasuhara A; Sakai-Tagawa Y; Lopes TJS; Kiso M; Yamayoshi S; Kinoshita N; Ohmagari N; Hattori SI; Takeda M; Mitsuya H; Krammer F; Suzuki T; Kawaoka Y
Proc Natl Acad Sci U S A; 2020 Jul; 117(28):16587-16595. PubMed ID: 32571934
[TBL] [Abstract][Full Text] [Related]
26. Delayed engagement of host defenses enables SARS-CoV-2 viremia and productive infection of distal organs in the hamster model of COVID-19.
Carrau L; Frere JJ; Golynker I; Fajardo A; Rivera CF; Horiuchi S; Roonprapunt T; Minkoff JM; Blanco-Melo D; TenOever B
Sci Signal; 2023 Jun; 16(789):eadg5470. PubMed ID: 37311033
[TBL] [Abstract][Full Text] [Related]
27. Evidence of SARS-CoV-2 infection in postmortem lung, kidney, and liver samples, revealing cellular targets involved in COVID-19 pathogenesis.
Falcón-Cama V; Montero-González T; Acosta-Medina EF; Guillen-Nieto G; Berlanga-Acosta J; Fernández-Ortega C; Alfonso-Falcón A; Gilva-Rodríguez N; López-Nocedo L; Cremata-García D; Matos-Terrero M; Pentón-Rol G; Valdés I; Oramas-Díaz L; Suarez-Batista A; Noa-Romero E; Cruz-Sui O; Sánchez D; Borrego-Díaz AI; Valdés-Carreras JE; Vizcaino A; Suárez-Alba J; Valdés-Véliz R; Bergado G; González MA; Hernandez T; Alvarez-Arzola R; Ramírez-Suárez AC; Casillas-Casanova D; Lemos-Pérez G; Blanco-Águila OR; Díaz A; González Y; Bequet-Romero M; Marín-Prida J; Hernández-Perera JC; Del Rosario-Cruz L; Marin-Díaz AP; González-Bravo M; Borrajero I; Acosta-Rivero N
Arch Virol; 2023 Feb; 168(3):96. PubMed ID: 36842152
[TBL] [Abstract][Full Text] [Related]
28. Proteomic and phosphoproteomic characteristics of the cortex, hippocampus, thalamus, lung, and kidney in COVID-19-infected female K18-hACE2 mice.
Liu JF; Peng WJ; Wu Y; Yang YH; Wu SF; Liu DP; Liu JN; Yang JT
EBioMedicine; 2023 Apr; 90():104518. PubMed ID: 36933413
[TBL] [Abstract][Full Text] [Related]
29. SARS-CoV-2 Variant Pathogenesis Following Primary Infection and Reinfection in Syrian Hamsters.
Plunkard J; Mulka K; Zhou R; Tarwater P; Zhong W; Lowman M; Wong A; Pekosz A; Villano J
mBio; 2023 Apr; 14(2):e0007823. PubMed ID: 37036339
[TBL] [Abstract][Full Text] [Related]
30. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.
Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A
mBio; 2021 Apr; 12(2):. PubMed ID: 33879586
[TBL] [Abstract][Full Text] [Related]
31. Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy.
Eskandarian Boroujeni M; Sekrecka A; Antonczyk A; Hassani S; Sekrecki M; Nowicka H; Lopacinska N; Olya A; Kluzek K; Wesoly J; Bluyssen HAR
Front Immunol; 2022; 13():888897. PubMed ID: 35663932
[TBL] [Abstract][Full Text] [Related]
32. Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Replication and Tropism in the Lungs, Airways, and Vascular Endothelium of Patients With Fatal Coronavirus Disease 2019: An Autopsy Case Series.
Bhatnagar J; Gary J; Reagan-Steiner S; Estetter LB; Tong S; Tao Y; Denison AM; Lee E; DeLeon-Carnes M; Li Y; Uehara A; Paden CR; Leitgeb B; Uyeki TM; Martines RB; Ritter JM; Paddock CD; Shieh WJ; Zaki SR
J Infect Dis; 2021 Mar; 223(5):752-764. PubMed ID: 33502471
[TBL] [Abstract][Full Text] [Related]
33. Severe acute respiratory syndrome coronaviruses contributing to mitochondrial dysfunction: Implications for post-COVID complications.
Prasada Kabekkodu S; Chakrabarty S; Jayaram P; Mallya S; Thangaraj K; Singh KK; Satyamoorthy K
Mitochondrion; 2023 Mar; 69():43-56. PubMed ID: 36690315
[TBL] [Abstract][Full Text] [Related]
34. Highly Neutralizing COVID-19 Convalescent Plasmas Potently Block SARS-CoV-2 Replication and Pneumonia in Syrian Hamsters.
Takamatsu Y; Imai M; Maeda K; Nakajima N; Higashi-Kuwata N; Iwatsuki-Horimoto K; Ito M; Kiso M; Maemura T; Takeda Y; Omata K; Suzuki T; Kawaoka Y; Mitsuya H
J Virol; 2022 Feb; 96(4):e0155121. PubMed ID: 34818068
[TBL] [Abstract][Full Text] [Related]
35. SARS-CoV-2 infection impairs the insulin/IGF signaling pathway in the lung, liver, adipose tissue, and pancreatic cells via IRF1.
Shin J; Toyoda S; Nishitani S; Onodera T; Fukuda S; Kita S; Fukuhara A; Shimomura I
Metabolism; 2022 Aug; 133():155236. PubMed ID: 35688210
[TBL] [Abstract][Full Text] [Related]
36. A Novel Glucocorticoid and Androgen Receptor Modulator Reduces Viral Entry and Innate Immune Inflammatory Responses in the Syrian Hamster Model of SARS-CoV-2 Infection.
Rocha SM; Fagre AC; Latham AS; Cummings JE; Aboellail TA; Reigan P; Aldaz DA; McDermott CP; Popichak KA; Kading RC; Schountz T; Theise ND; Slayden RA; Tjalkens RB
Front Immunol; 2022; 13():811430. PubMed ID: 35250984
[TBL] [Abstract][Full Text] [Related]
37. Simulation of the Clinical and Pathological Manifestations of Coronavirus Disease 2019 (COVID-19) in a Golden Syrian Hamster Model: Implications for Disease Pathogenesis and Transmissibility.
Chan JF; Zhang AJ; Yuan S; Poon VK; Chan CC; Lee AC; Chan WM; Fan Z; Tsoi HW; Wen L; Liang R; Cao J; Chen Y; Tang K; Luo C; Cai JP; Kok KH; Chu H; Chan KH; Sridhar S; Chen Z; Chen H; To KK; Yuen KY
Clin Infect Dis; 2020 Dec; 71(9):2428-2446. PubMed ID: 32215622
[TBL] [Abstract][Full Text] [Related]
38. Alteration of L-Dopa decarboxylase expression in SARS-CoV-2 infection and its association with the interferon-inducible ACE2 isoform.
Mpekoulis G; Frakolaki E; Taka S; Ioannidis A; Vassiliou AG; Kalliampakou KI; Patas K; Karakasiliotis I; Aidinis V; Chatzipanagiotou S; Angelakis E; Vassilacopoulou D; Vassilaki N
PLoS One; 2021; 16(6):e0253458. PubMed ID: 34185793
[TBL] [Abstract][Full Text] [Related]
39. Angiotensin-Converting Enzyme 2 Potentiates SARS-CoV-2 Infection by Antagonizing Type I Interferon Induction and Its Down-Stream Signaling Pathway.
Chen J; Liu J; Chen Z; Peng H; Zhu C; Feng D; Zhang S; Zhao P; Zhang X; Xu J
mSphere; 2022 Aug; 7(4):e0021122. PubMed ID: 35862802
[TBL] [Abstract][Full Text] [Related]
40. Kinetic Multi-omic Analysis of Responses to SARS-CoV-2 Infection in a Model of Severe COVID-19.
Cantwell AM; Singh H; Platt M; Yu Y; Lin YH; Ikeno Y; Hubbard G; Xiang Y; Gonzalez-Juarbe N; Dube PH
J Virol; 2021 Sep; 95(20):e0101021. PubMed ID: 34319784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
